A Prospective, Phase 3, Multi-Center, Single-Arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA-7.3 (18F) PET Ligand in Men with Newly Diagnosed Prostate Cancer

Administered By

Awarded By

Contributors

Start/End

  • July 2, 2020 - June 30, 2022